Diffusion Pharmaceuticals Announces Stock Ticker Symbol Change to DFFN
Jan 25, 2016 12:30 pm UTC| Business
CHARLOTTESVILLE, Va., Jan. 25, 2016 -- Diffusion Pharmaceuticals Inc., a clinical stage biotechnology company focused on the development of novel small molecule therapeutics for cancer, today announced that FINRA has...
Jan 25, 2016 12:22 pm UTC| Business
Deerfield Beach, FL, Jan. 25, 2016 -- Zion Research has published a new report titled “mHealth Devices (Glucose Monitors, Blood Pressure Monitors, Cardiac Monitors, Pulse Oximeters, Sleep Apnea Monitors, Multi-parameter...
AlixPartners Boosts China Business with Senior Hire
Jan 25, 2016 12:12 pm UTC| Business
NEW YORK, Jan. 25, 2016 -- AlixPartners, the global business advisory firm, today announced that industry veteran George Geh has joined as a Managing Director in the firm's Shanghai office, effective January 4,...
Jan 25, 2016 12:09 pm UTC| Business
Deerfield Beach, FL, Jan. 25, 2016 -- Zion Research has published a new report titled “Coenzyme Q10 Market for Dietary Supplements, Pharmaceuticals, Cosmetics and Others Applications: Global Industry Perspective,...
ANSYS to Release Fourth Quarter and FY 2015 Earnings on February 25, 2016
Jan 25, 2016 12:09 pm UTC| Business
PITTSBURGH, Jan. 25, 2016 -- ANSYS, Inc. (NASDAQ:ANSS) announced today that the Company expects to release its fourth quarter and FY 2015 earnings on Thursday, February 25, 2016. The Company will hold a conference call...
Four New Patents Issued, PROCYSBI® Granted Additional U.S. Orphan Exclusivity
Jan 25, 2016 12:05 pm UTC| Business
Five Patents for PROCYSBI Now Listed in FDA Orange Book Orphan Drug Exclusivity Extended in Nephropathic Cystinosis Patients 2-6 Years Old NOVATO, Calif., Jan. 25, 2016 -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP)...
Novavax Announces Proposed Offering of $200 Million of Convertible Senior Notes Due 2023
Jan 25, 2016 12:00 pm UTC| Business
GAITHERSBURG, Md., Jan. 25, 2016 -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today...